TrialHepatology (Baltimore, Md.)2015

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity.

Alla Kachko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.